Evidence map›Paper›PMID 27307576›Full record

ArticleJournal of lipid research2016

EPA prevents fat mass expansion and metabolic disturbances in mice fed with a Western diet.

Alexandre Pinel, Elodie Pitois, Jean-Paul Rigaudiere, Chrystele Jouve, Sarah De Saint-Vincent, Brigitte Laillet, Christophe Montaurier, Alain Huertas, Beatrice Morio, Frederic Capel

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Do patients benefit from omega-3 fatty acids?Cardiovascular research · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Alexandre PinelUMR 1019, Unité de Nutrition Humaine, INRA, Université d'Auvergne, CRNH, Clermont-Ferrand, France.
Elodie PitoisUMR 1019, Unité de Nutrition Humaine, INRA, Université d'Auvergne, CRNH, Clermont-Ferrand, France.
Jean-Paul RigaudiereUMR 1019, Unité de Nutrition Humaine, INRA, Université d'Auvergne, CRNH, Clermont-Ferrand, France.
Chrystele JouveUMR 1019, Unité de Nutrition Humaine, INRA, Université d'Auvergne, CRNH, Clermont-Ferrand, France.
Sarah De Saint-VincentUMR 1019, Unité de Nutrition Humaine, INRA, Université d'Auvergne, CRNH, Clermont-Ferrand, France.
Brigitte LailletUMR 1019, Unité de Nutrition Humaine, INRA, Université d'Auvergne, CRNH, Clermont-Ferrand, France.
Christophe MontaurierUMR 1019, Unité de Nutrition Humaine, INRA, Université d'Auvergne, CRNH, Clermont-Ferrand, France.
Alain HuertasLesieur-Groupe Avril 29, quai Aulagnier Asnières-sur-Seine Cedex, France.
Beatrice MorioUMR 1019, Unité de Nutrition Humaine, INRA, Université d'Auvergne, CRNH, Clermont-Ferrand, France INRA, UMR 1397, Laboratoire Carmen, Université Lyon 1, INSERM U1060, INSA de Lyon, Universités Rockefeller et Charles Merieux Lyon-sud, Lyon, France.
Frederic CapelUMR 1019, Unité de Nutrition Humaine, INRA, Université d'Auvergne, CRNH, Clermont-Ferrand, France frederic.capel@clermont.inra.fr.
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRUnité de Nutrition Humaine · FRCentre de Recherche en Nutrition Humaine d'Auvergne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The impact of alpha linolenic acid (ALA), EPA, and DHA on obesity and metabolic complications was studied in mice fed a high-fat, high-sucrose (HF) diet. HF diets were supplemented with ALA, EPA, or DHA (1% w/w) and given to C57BL/6J mice for 16 weeks and to Ob/Ob mice for 6 weeks. In C57BL/6J mice, EPA reduced plasma cholesterol (-20%), limited fat mass accumulation (-23%) and adipose cell hypertrophy (-50%), and reduced plasma leptin concentration (-60%) compared with HF-fed mice. Furthermore, mice supplemented with EPA exhibited a higher insulin sensitivity (+24%) and glucose tolerance (+20%) compared with HF-fed mice. Similar effects were observed in EPA-supplemented Ob/Ob mice, although fat mass accumulation was not prevented. By contrast, in comparison with HF-fed mice, DHA did not prevent fat mass accumulation, increased plasma leptin concentration (+128%) in C57BL/6J mice, and did not improve glucose homeostasis in C57BL/6J and Ob/Ob mice. In 3T3-L1 adipocytes, DHA stimulated leptin expression whereas EPA induced adiponectin expression, suggesting that improved leptin/adiponectin balance may contribute to the protective effect of EPA. In conclusion, supplementation with EPA, but not ALA and DHA, could preserve glucose homeostasis in an obesogenic environment and limit fat mass accumulation in the early stage of weight gain.

Indexed as

3T3-L1 CellsAdipogenesisAdipokinesAdipose Tissue, WhiteAdiposityAnimalsAnti-Obesity AgentsCell MembraneDiet, WesternDrug Evaluation, PreclinicalEicosapentaenoic AcidErythrocytesGene ExpressionGlucose IntoleranceInsulin ResistanceLeptinAdipokinesAnti-Obesity AgentsEicosapentaenoic AcidLeptinPhospholipidsadipose tissueeicosapentaenoic acidinsulin resistanceobesityomega-3 polyunsaturated fatty acid

Identifiers

PMID27307576
PMCPMC4959855
OpenAlexW2430504706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.